AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 283: H1005-H1011, 2002. First published May 16, 2002; doi:10.1152/ajpheart.00054.2002
0363-6135/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/3/H1005    most recent
00054.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, K.
Right arrow Articles by Busija, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, K.
Right arrow Articles by Busija, D. W.
Vol. 283, Issue 3, H1005-H1011, September 2002

MitoKATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat

Katsuyoshi Shimizu1, Zsombor Lacza1,2, Nishadi Rajapakse1, Takashi Horiguchi1, James Snipes1, and David W. Busija1

1 Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1083; and 2 Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest, Hungary 1082


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We investigated effects of diazoxide, a selective opener of mitochondrial ATP-sensitive K+ (mitoKATP) channels, against brain damage after middle cerebral artery occlusion (MCAO) in male Wistar rats. Diazoxide (0.4 or 2 mM in 30 µl saline) or saline (sham) was infused into the right lateral ventricle 15 min before MCAO. Neurological score was improved 24 h later in the animals treated with 2 mM diazoxide (13.8 ± 0.7, n = 13) compared with sham treatment (9.5 ± 0.2, n = 6, P < 0.01). The total percent infarct volume (MCAO vs. contralateral side) of sham treatment animals was 43.6 ± 3.6% (n = 12). Treatment with 2 mM diazoxide reduced the infarct volume to 20.9 ± 4.8% (n = 13, P < 0.05). Effects of diazoxide were prominent in the cerebral cortex. The protective effect of diazoxide was completely prevented by the pretreatment with 5-hydroxydecanoate (100 mM in 10 µl saline), a selective blocker of mitoKATP channels (n = 6). These results indicate that selective opening of the mitoKATP channel has neuroprotective effects against ischemia-reperfusion injury in the rat brain.

ischemia; stroke; cerebral circulation; mitochondrial adenosine 5'-triphosphate-sensitive potassium channels


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

WHILE THE MAIN FUNCTION of mitochondria is ATP synthesis, these intracellular organelles also play a major role in mediating cellular responses to ischemic stress. For example, calcium influx into mitochondria and the opening of mitochondrial permeability transition pores appear to be early steps leading to necrotic and apoptotic cell death in various tissues and organs including the brain (19, 29). Additionally, numerous studies have shown that the pharmacological targeting of mitochondrial ATP-sensitive K+ (mitoKATP) channels, with acute administration of drugs such as diazoxide, protects ischemic myocardium against injury (17, 30). Diazoxide is a selective opener of mitoKATP channels and has minimal effects on sarcolemmal KATP channels (10, 20, 31). Furthermore, transient activation of mitoKATP channels with sublethal ischemia appears to be a crucial step in the development of ischemic preconditioning, which protects myocytes from subsequent prolonged ischemia (15, 17). Protective effects of acute administration of diazoxide or ischemic preconditioning can be prevented by 5-hydroxydecanoate (5-HD), a selective antagonist of mitoKATP channels (15, 20, 31), whereas a selective inhibitor of sarcolemmal KATP channels has no protective effect (15). While the mechanism of acute cellular protection by diazoxide is not completely understood, one possible explanation is that the opening of the mitoKATP channel minimizes calcium influx, mitochondrial swelling, and subsequent injury by depolarizing the membranes of these organelles (15, 21, 35).

In contrast to the heart, little is known about possible cellular protective effects of mitoKATP channel activation in the brain. For example, only two studies have specifically targeted mitoKATP channels in an attempt to protect the brain against ischemic or anoxic stresses. Thus Domoki et al. (13) have shown that diazoxide administration preserves neuronal function after 10 min of ischemic stress in the piglet cerebral cortex. This protective effect was reversed with coapplication of 5-HD. In the other study, diazoxide prevented cell injury in brain slices during 30 min of anoxia (4). We are unaware of any previous reports except for our own preliminary findings (7, 38) concerning the effects of mitoKATP channel opening on infarct volume after ischemia-reperfusion injury in the brain.

In the present study, we explored the potential for the mitoKATP channel to protect the brain against ischemic insult. First, we used immunoblotting techniques to establish the presence of essential subunits (inward rectifying K+ channel and sulfonylurea receptor) of the KATP channel on brain mitochondria. We chose to examine the Kir6.1 and sulfonylurea receptor (SUR)2 subunits based on previous studies (5, 47) and pilot experiments. Second, we evaluated the direct effect of diazoxide on membrane potential (Delta Psi m) of rat brain isolated mitochondria using fluorescent approaches. Third, we investigated whether pharmacological opening of the mitoKATP channel would limit ischemic damage after transient middle cerebral artery (MCA) occlusion (MCAO) in the rat. Finally, we examined the effects of diazoxide on cerebral blood flow (CBF) and arterial blood pressure during control, ischemic, and postischemic conditions.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

All experiments were performed on male Wistar rats weighing 190-210 g. The procedures were approved by the Institutional Animal Care and Use Committee.

Mitochondria preparation. Pure, isolated mitochondria preparations from the rat brain were collected using a discontinuous percoll gradient method (27, 37, 41). This protocol offers sufficient yield with very low contamination from other organelles (1-4%), as demonstrated by electron microscopy and by Western blotting for proteins associated with contaminating structures (27, 34). Additionally, we have shown that mitochondria isolated by this method maintain a Delta Psi m, have normal respiratory values, and continue to import proteins via an energy-dependent mechanism (34). Adult male Wistar rats were anesthetized with thiopental sodium (250 mg/kg ip) and decapitated. The brain was removed and homogenized by eight strokes of a Teflon-glass motorized tissue grinder (Wheaton; Milville, NJ) in isolation buffer containing 12% percoll (Amersham Pharmacia; Uppsala, Sweden). Mitochondria were isolated in sucrose buffer containing 0.32 M sucrose, 1 mM EDTA, and 10 mM Tris · HCl; pH 7.4. The resulting suspension was centrifuged for 3 min at 3,000 rpm, and the middle layer was saved and layered on top of a discontinuous percoll gradient (24/40%). The gradient was centrifuged for 5 min at 19,000 rpm, and the third layer containing the purified mitochondria was collected. The preparation was washed in isolation buffer and centrifuged for 10 min at 14,000 rpm, and the pellet was used for further investigations. All procedures were performed on ice.

Western blotting. Protein was extracted from freshly isolated mitochondria by the addition of boiling lysis buffer [containing 1% (vol/vol) of 1 mol/l Tris and 1% (wt/vol) sodium dodecyl sulphate]. The samples were sonicated, heated at 95°C for 5 min, and centrifuged for 20 min at 12,000 rpm at 4°C. The supernatant was used for immunoblotting. Protein concentration was measured by a Bio-Rad DC protein assay kit (Bio-Rad Laboratories; Hercules, CA). An equal volume of sample buffer [45% (vol/vol) of 0.5 mol/l Tris (pH 6.8), 45% (vol/vol) glycerol, 10% (vol/vol) H2O, 0.75 mg/ml bromophenol blue, and 90 mg/ml sodium dodecyl sulphate] was added to each sample. Equal amounts of protein were separated on a 4-20% gradient mini gel (Bio-Rad) and transferred to a polyvinylidene difluoride membrane. After the membrane was blocked with 3% bovine serum albumin, primary antibodies against the KATP receptor subunits Kir6.1 or SUR2 (Santa Cruz Biotechnology; Santa Cruz, CA) were applied followed by horseradish peroxidase-conjugated secondary antibody. Chemiluminescence was used to visualize the bands. Molecular mass markers (Bio-Rad) were included on each blot. Specificity of the method was tested by omitting the primary antibody from the procedure or preabsorption with the respective blocking peptides, which resulted in the disappearance of the specific bands (data not shown).

Fluorescent microscopy. Freshly isolated mitochondria were dispersed in buffer containing 125 mM KCl, 2 mM K2HPO4, 5 mM MgCl2, 10 mM HEPES, 10 µM EGTA, 5 mM Na-malate, and 5 mM Na-glutamate at pH 7.0. The mitochondria were visualized using a Zeiss scanning confocal microscope with a fluorescein filter set. Mitochondrial Delta Psi m was monitored by the addition of 2 µg/ml rhodamine-1,2,3 (36). Three subsequent images were recorded from each preparation: 1) baseline, 2) with the addition of diazoxide (0.1 mM), and 3) with the addition of nigericin (0.01 mM). The ionophore nigericin served as a positive control, because it fully decreases the transmembrane proton gradient (Delta pH) and converts it to Delta Psi m. Mitochondrial autofluorescence was routinely recorded in each preparation before adding rhodamine-1,2,3. The intensity of autofluorescence of the mitochondria was negligible compared with the intensity after addition of rhodamine-1,2,3.

MCAO experiments. Animals were fasted overnight with access to water before surgery. After anesthesia was induced with 5% halothane in 95% oxygen, endotracheal intubation was performed, and all the animals were mechanically ventilated with 1.0-1.5% halothane in a 70:30 gas mixture of N2O and O2 (SAR-830 Ventilator, CWE). The tail artery was cannulated for continuous monitoring of mean arterial blood pressure (MABP; model 300, Blood Pressure Analyzer, Digi-Med) and intermittent sampling of arterial blood for determination of gases and pH. The head was then stabilized in a stereotactic frame, and a hole was made in the skull. A total amount of 30 µl diazoxide (0.4 mM, n = 6, or 2 mM, n = 13) was infused into the right lateral ventricle (AP, -0.8 mm, lateral 1.5 mm, and dorsoventral 3.5 mm), according to the rat brain atlas (32) 15 min before the induction of ischemia (9). Diazoxide was initially dissolved in a small amount of dimethyl sulfoxide (DMSO) and further diluted in buffered saline. Additionally, we studied a sham-treated group (n = 12) in which one-half of the rats were treated with 30 µl buffered saline alone and the other half were treated with an appropriate amount of DMSO in 30 µl buffered saline. This amount of DMSO corresponded to that administered with the higher dose of diazoxide. Because there were no substantial differences in total infarct volume between these two vehicle groups (41.9 ± 6.7% saline alone vs. 45.3 ± 7.1% DMSO in saline), the data were combined into one sham group. Finally, we examined the specificity of the effect of diazoxide using the mitochondrial KATP channel inhibitor 5-HD. Ten microliters of 100 mM 5-HD was infused into the right lateral ventricle over 20 s, 5 min before the treatment with the high dose of diazoxide (n = 6).

Immediately after the intraventricular administration of drugs (diazoxide alone at two doses or 2 mM diazoxide plus 5-HD) or saline, wounds were closed and the rats were released from the stereotactic frame. Transient focal cerebral ischemia was induced using the MCAO filament model as previously described with some modifications (39, 45). In brief, a midline neck incision was made, and, after exposure, the external (ECA) and internal carotid arteries (ICA) were dissected from surrounding connective tissue. The branches of the ECA were ligated and cut. The ECA was then ligated in two places and divided. Two microvascular clips were placed across the common carotid artery and the ICA, respectively. A 4-0 monofilament nylon suture (Ethicon) was introduced into the ICA via the ECA stump. The tip of filament was coated with silicon (Rhodoia RTV 1556 A and B). The suture was inserted ~20 mm until some resistance was felt and a slight curving of the suture was observed within the ICA lumen. The suture around the ECA stump was then tightened. The proximal microvascular clip was removed, and the incision was closed. During surgery, the rectal temperature was maintained at normal values by a heating pad. After awakening from anesthesia, rats were extubated and kept in the cage during 90 min of MCAO. The animals were then briefly anesthetized, the suture was removed, and the stump of the ECA was ligated by 5-0 silk sutures. The rats were kept in a cage and allowed free access to food and water.

Neurological evaluation was performed 24 h after reperfusion according to procedures described by Garcia et al. (16). Specifically, we evaluated spontaneous activity, symmetry in the movement of four limbs, forepaw outstretching, climbing, body proprioception, and response to vibrissae touch. These six tests were each scored from 0 to 3, which means that behavioral deficits were graded on a total score from 0 to 18. Lower scores represent more serious neurological deficits. This procedure has been shown to accurately measure neurological deficits in experimental strokes.

After neurological evaluation, all animals were anesthetized and decapitated, and the brains were removed. The brains with subarachnoid hemorrhage and/or clot formation in the MCA were eliminated from the analysis in this study. All verified brains were sliced into sections of 2 mm thickness. Each slice was incubated for 20 min in a 2% solution of 2,3,5-triphenyltetrazolium chloride (TTC; Sigma) at room temperature and then fixed in 10% buffered formaldehyde solution. Prior determinations of brain size in three naïve animals after MCAO failed to show side differences (data not shown), which made the indirect measurement of infarct volume valid according to published criteria (28, 42). The cross-sectional area of infarction in the right MCA territory of each brain slice was determined with a computerized image analysis system (NIH Image version 1.62) according to the indirect method proposed by Swanson and others (28, 42). Infarct volumes were calculated by summation of the infarcted area of six brain slices (2-14 mm from frontal pole), integrated by the thickness (2 mm), and expressed as the percentage of contralateral hemispheric volume (percent infarction). Percent infarctions of the whole brain, cortex, and basal ganglia were compared among different treatments.

CBF assessment during MCAO. CBF was measured on the right front parietal cortex with a laser Doppler flowmeter (Multichannel Laser Doppler System, PERIMED) during resting conditions, during ischemia, and during reperfusion in two groups of rats. MABP was also measured during the same conditions. We have used these procedures previously (37). One group of rats received 2 mM in 30 µl saline infused into the right lateral ventricle before MCAO (n = 6). Another six sham animals received either saline alone (n = 2) or DMSO in saline (n = 4) infused into the right lateral ventricle before MCAO.

Statistical analysis. Data are expressed as means ± SE. The physiological parameters among different treatment groups were compared by one-way ANOVA. Neurological score was compared among all treatment groups 24 h after ischemia by one-way ANOVA followed by Fisher least-significant-difference post hoc analysis. The percent infarction was compared among different treatments by one-way ANOVA followed by Fisher least-significant-difference post hoc analysis or t-test, whichever was appropriate. A P value <0.05 was regarded as statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Immunoblotting. Both necessary subunits, which are required for a functional KATP channel, were found in isolated brain mitochondria. The specific antibody for the inwardly rectifying K+ channel (Kir6.1) recognized a single band of ~50 kDa (Fig. 1B). This band is enriched in mitochondria, showing that the primary localization of the Kir6.1 subunit in the brain is in this organelle. Similarly, the anti-SUR2 antibody recognized a specific band of ~130 kDa, which was also enriched in the mitochondria compared with the full brain tissue level (Fig. 1A). We also compared the amounts of intact Kir6.1- and SUR2-immunoreactive bands in the territory affected by MCAO with the contralateral, nonischemic side. However, we were unable to detect any substantial differences in the intensity of the bands from either side for either subunit (data not presented).


View larger version (85K):
[in this window]
[in a new window]
 
Fig. 1.   Western blots using antibodies against sulfonylurea receptor (SUR)2 (A) or Kir6.1 (B) for the whole brain and isolated brain mitochondria (mito). Immunopositive bands were present for each protein in both brain and brain mitochondria, and, on a per weight basis, both bands showed enrichment of respective proteins in mitochondria compared with the whole brain.

Fluorescent study. Autofluorescence was negligible before application of rhodamine-1,2,3. During baseline conditions, the mitochondria showed a weak fluorescent signal with rhodamine-1,2,3 (Fig. 2A). The addition of diazoxide increased the intensity of fluorescence, indicating a decrease in Delta pH (Fig. 2B). As a positive control, we added the ionophore nigericin. Nigericin fully converts Delta pH to Delta Psi m and maximizes the fluorescent signal (data not shown). Thus the addition of diazoxide markedly alters mitochondrial function through the depolarization of the inner membrane.


View larger version (121K):
[in this window]
[in a new window]
 
Fig. 2.   Confocal fluorescent images of isolated rat brain mitochondria using the fluorophore rhodamine-1,2,3. Left, mitochondria in transmitted light with DIC optics; right, fluorescence of the same field. A: baseline condition; B: in the presence of diazoxide (0.1 mM).

MCAO. In all animals studied, the systemic physiological parameters measured were kept within the normal range throughout the manipulations. The treatment groups did not differ with respect to rectal temperature, blood gases, glucose, or blood pressure (data not shown).

The neurological score 24 h after reperfusion showed a reduced data value for the sham group (Fig. 3). Although not significant, pretreatment with 0.4 mM diazoxide tended to increase the neurological score. Pretreatment with 2 mM diazoxide significantly improved the neurological score compared with sham animals. In contrast, coapplication of 5-HD abolished the effect of 2 mM diazoxide and reduced the neurological score to values similar to sham animals.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 3.   Neurological scores 24 h after transient middle cerebral artery occlusion (MCAO). Values are means ± SE. Treatment with 2 mM diazoxide significantly improved the neurological scores 24 h after transient MCAO compared with sham treatment. Although not significant, treatment with 0.4 mM diazoxide tended to increase the neurological score. Administration of 5-hydroxydecanoate (2 mM diazoxide + 5-HD) completely abolished the protective effect of 2 mM diazoxide. *P < 0.01 vs. sham and P < 0.05 vs. 2 mM diazoxide + 5-HD.

Treatment with 2 but not 0.4 mM diazoxide decreased infarct volume after MCAO compared with sham animals (Figs. 4 and 5). The total percent infarction was 43.6 ± 3.6% in the sham animals. Whereas treatment with 0.4 mM diazoxide did not show any protective effects (42.4 ± 9.6%), treatment with 2 mM diazoxide decreased the total percent infarction by approximately one-half (20.9 ± 4.8%, P < 0.05 vs. sham). The effect of 2 mM diazoxide was completely abolished by the pretreatment with 5-HD (50.9 ± 9.2%, P < 0.01 vs. 2 mM diazoxide). Focusing on the cortex, 2 mM diazoxide significantly diminished the percent infarction, and this effect was completely abolished by the pretreatment with 5-HD (Fig. 5). Similar in direction but smaller effects of 2 mM diazoxide were seen in the basal ganglia, and again the protective effects of diazoxide were eliminated by 5-HD (Fig. 5). Treatment with 0.4 mM diazoxide had no effect on infarct size in either brain area.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Representative coronal sections of 2,3,5-triphenyltetrazolium chloride-stained brains 24 h after MCAO. Left, slice from the brain of a sham-treated animal; right, slice from the brain of an animal receiving 2 mM diazoxide. Infarction size was less in the diazoxide-treated animal.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Infarct volume 24 h after transient MCAO. Values are means ± SE. For the cortex and basal ganglia, the treatment with 2 mM diazoxide reduced the infarction size compared with the saline treatment. Coapplication of 5-HD with 2 mM diazoxide (2 mM diazoxide + 5-HD) prevented this reduction. Treatment with 0.4 mM diazoxide did not affect infarct volume. *P < 0.05 vs. sham and P < 0.01 vs. 2 mM diazoxide + 5-HD; **P < 0.05 vs. sham and P < 0.01 vs. 2 mM diazoxide + 5-HD.

Diazoxide or vehicle did not alter resting CBF or arterial blood pressure (Fig. 6). In addition, the reductions in CBF during MCAO were similar in the two experimental groups (Fig. 6). Finally, CBF was similar during the reperfusion period in diazoxide-treated and sham animals.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   Cerebral blood flow (CBF) and mean arterial blood pressure (MABP) in animals treated with diazoxide (2 mM in 30 µl saline, n = 6) or in sham animals (n = 6) during the ischemia and reperfusion periods. Values are means ± SE. The left y-axis indicates CBF expressed as a percentage of the control value. The right y-axis shows MABP expressed as a percentage of the control value. There were no significant differences in CBF and MABP between the two groups.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The major new finding from the present experiments is that the pretreatment with the mitoKATP channel opener diazoxide had a neuroprotective effect against transient focal cerebral ischemia in the rat. While decreases in infarct volume were particularly prominent in the cerebral cortex, significant neuroprotection also occurred in subcortical areas. The neuroprotective effects of diazoxide were reversed by coadministration of 5-HD. Additionally, data from isolated mitochondria provide evidence that the obligatory subunits of KATP channels are present in these organelles and that diazoxide-induced dissipation of Delta Psi m may be involved in this protective effect. Finally, CBF responses to ischemia and reperfusion were unaffected by diazoxide treatment. Thus the selective targeting of the mitoKATP channel appears to lessen the impact of ischemic insult to the brain.

The current study supports and extends earlier results from studies in our laboratory and from another laboratory. In the first study, we found that diazoxide treatment given before 10 min of global ischemia preserved normal dilator responses of cortical arterioles to topical application of N-methyl-D-asparate (NMDA) (13). Application of NMDA induces dilation via production of nitric oxide (NO) by cortical neurons and subsequent diffusion of NO to surface arterioles, where NO relaxes vascular smooth muscle cells (13). Typically, ischemia-reperfusion dramatically decreases arterial dilation to NMDA via a mechanism involving altered function of NMDA receptors located on neurons. In the second study, diazoxide treatment protected cortical cells in brain slices during 30 min of anoxia (4). Limitations of these studies are that only immediate effects (30-60 min) and not long-term effects of anoxia were examined and the responses of noncortical cells were not investigated. Furthermore, in the latter study, it is unclear whether diazoxide treatment prevented or simply prolonged survival of neocortical cells, because under anoxic conditions without reoxygenation it is expected that all neurons would eventually die. These initial studies provide circumstantial evidence for the participation of mitoKATP channels in neuroprotection.

The combination of several different approaches in the present study provides the first direct evidence for an important role of the mitoKATP channel in limiting the neurological injury due to MCAO. Administration of diazoxide, a specific activator of mitoKATP channels, limited the extent of death of both cortical and subcortical neurons against 90 min of ischemia induced by transient MCAO (10, 20, 31). Thus, 24 h after reperfusion, dramatic reductions in infarct volume were seen in diazoxide-treated animals compared with sham animals. Furthermore, coadministration of 5-HD, a highly selective antagonist of mitoKATP channels, completely reversed neuroprotection (15, 20, 31). Brain infarct volume was similar in animals receiving vehicle or 5-HD alone before ischemia (unpublished observations). In addition, we found that both obligatory subunits required for a functional KATP channel were found in isolated brain mitochondria. The specific antibody for the inwardly rectifying K+ channel (Kir6.1) recognized a single band of ~50 kDa. Similarly, the specific antibody against SUR2 recognized a specific band of ~130 kDa. These bands are enriched in mitochondria compared with brain tissue, indicating the importance of these K+ channels to function of these organelles. The molecular masses for these subunits are comparable with values reported by other investigators (1, 4, 5, 47). Additionally, fluorescent approaches established the ability of diazoxide to depolarize mitochondria.

Although we (45) and other investigators (4, 18, 43) have shown that nonspecific K+ channel agonists have similar protective effects, we believe that this is the first report of the administration of a selective mitoKATP channel opener increasing neuronal survival after transient brain ischemia (43). However, precise mechanisms by which mitoKATP channel activation protects the brain are unclear. We believe that indirect protective effects via increases in CBF are unlikely, because our previous studies indicate that diazoxide does not affect tone of cerebral arteries (13), and the present results indicate that CBF responses during and after ischemia are similar in diazoxide-treated and sham animals. One possible mechanism is that acute activation of mitoKATP channel results in K+ influx, organelle depolarization, and expansion of mitochondrial matrix volume. The results of our fluorescent experiments provide direct evidence that diazoxide can decrease Delta Psi m in brain mitochondria. Regulation of matrix volume is an essential element in the regulation of mitochondrial energy production. For example, matrix expansion has been postulated to activate electron transport and stimulate mitochondrial metabolism, which may "cushion" cells against transient ischemic events (15, 22). Additionally, mitochondrial membrane depolarization induced by K+ influx through mitoKATP channels is expected to dissipate Delta Psi m and thereby decrease Ca2+ influx during ischemia. Thus the driving force for Ca2+ influx through the Ca2+ uniport is reduced, consequently attenuating mitochondrial Ca2+ overload (12, 14, 23). Mitochondrial Ca2+ overload has been closely correlated with mitochondrial damage, which results in both necrotic and apoptotic forms of cell death (2, 8, 23, 40, 44). For example, the accumulation of Ca2+ in mitochrondria damages complex I of the electron transport chain (22), increases production of reactive oxygen species, and causes formation of mitochondrial permeability transition pores, all of which can lead to cell death (6, 11, 25, 33). Thus, in addition to increasing energy production before ischemia, diazoxide treatment may also protect neurons by attenuating or delaying mitochondrial Ca2+ overload.

In conclusion, the present study has provided the first direct evidence that selective opening of the mitoKATP channel provides neuroprotection against ischemia-reperfusion in the rat brain. Thus, despite profound differences in cellular physiology and sensitivity to anoxic injury between myocardial cells and neurons, the same pharmacological approach has been shown to protect the heart and brain, respectively, against ischemia-reperfusion injury.


    ACKNOWLEDGEMENTS

This research was supported by National Heart, Lung, and Blood Institute Grants HL-30260, HL-46558, and HL-50587, American Heart Association (AHA) Mid-Atlantic Affiliate Grant 99512724, and AHA Bugher Foundation Award 0270114. N. Z. Lacza was partially supported by the Hungarian National Eötvös Fellowship.


    FOOTNOTES

Address for reprint requests and other correspondence: K. Shimizu, Dept. of Neurosurgery, Tachikawa Hospital, 4-2-22 Nishikicho Tachikawa-shi, Tokyo 190-8531, Japan (E-mail: KATSUYOSHIS{at}aol.com).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

May 16, 2002;10.1152/ajpheart.00054.2002

Received 22 January 2002; accepted in final form 7 May 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Aguilar-Bryan, L, and Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20: 101-135, 1999[Abstract/Free Full Text].

2.   Akao, M, Ohler A, O'Rourke B, and Marbán E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res 88: 1267-1275, 2001[Abstract/Free Full Text].

3.   Anderson, MF, and Sims NR. Mitochondrial respiratory function and cell death in focal cerebral ischemia. J Neurochem 73: 1189-1199, 1999[Web of Science][Medline].

4.   Arriba, SG, Franke H, Pissarek M, Nieber K, and Illes P. Neuroprotection by ATP-dependent potassium channels in rat neocortical brain slices during hypoxia. Neurosci Lett 273: 13-16, 1999[Web of Science][Medline].

5.   Bajgar, R, Seetharaman S, Kowaltowski AJ, Garlid KD, and Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 276: 33369-33374, 2001[Abstract/Free Full Text].

6.   Buja, LM. Modulation of the myocardial response to ischemia. Lab Invest 78: 1345-1373, 1998[Web of Science][Medline].

7.   Busija, DW, Shimizu K, and Rajapakse N. Selective activation of mitochodrial ATP-sensitive potassium channels by diazoxide limits infarct volume following transient focal cerebral ischemia in rats. Circulation 104: II-175, 2001.

8.   Crompton, M. The mitochondrial permeability transition pore and its role in cell death. J Biochem 341: 127-132, 1999.

9.   Cui, JK, Hsu CY, and Liu PK. Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide. J Neurosci 19: 1335-1344, 1999[Abstract/Free Full Text].

10.   Debska, G, May R, Kicinska A, Szewczyk A, Elger CE, and Kunz WS. Potassium channel openers depolarize hippocampal mitochondria. Brain Res 892: 42-50, 2001[Web of Science][Medline].

11.   Di Lisa, F, and Bernardi P. Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem 184: 379-391, 1998[Web of Science][Medline].

12.   Di Lisa, F, Manabo R, Canton M, and Petronilli V. The role of mitochondria in the salvage and injury of the ischemic myocardium. Biochim Biophys Acta 1366: 69-78, 1998[Medline].

13.   Domoki, F, Perciaccante JV, Veltkamp R, Bari F, and Busija DW. Mitochondrial potassium channel opener diazoxide preserves neuronal-vascular function after cerebral ischemia in newborn pigs. Stroke 30: 2713-2719, 1999[Abstract/Free Full Text].

14.   Ferrari, R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol 28, Suppl1: S1-S10, 1996[Web of Science][Medline].

15.   Fryer, RM, Eells JT, Hsu AK, Henry MM, and Gross GJ. Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol 278: H305-H312, 2000[Abstract/Free Full Text].

16.   Garcia, JH, Wagner S, Liu KF, and Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26: 627-635, 1995[Abstract/Free Full Text].

17.   Garlid, KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, and Grover GJ. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Circ Res 81: 1072-1082, 1997[Abstract/Free Full Text].

18.   Gribkoff, VK, Starrett JE, Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, and Yeola SW. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7: 471-477, 2001[Web of Science][Medline].

19.   Griffiths, JE. Mitochondria-potential role in cell life and death. Cardiovasc Res 46: 24-27, 2000[Free Full Text].

20.   Gross, GJ, and Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 84: 973-979, 1999[Abstract/Free Full Text].

21.   Grover, GJ, Dzwonczyk S, and Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891. Eur J Pharmacol 191: 11-19, 1990[Web of Science][Medline].

22.   Halestrap, AP. Regulation of mitochondrial metabolism through changes in matrix volume. Biochem Soc Trans 22: 522-529, 1994[Web of Science][Medline].

23.   Halestrap, AP, Kerr PM, Javadov S, and Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366: 79-94, 1998[Medline].

24.   Hardy, L, Clark J, Darley-Usmar V, Smith D, and Stone D. Reoxygenation dependent decrease in mitochondrial NADH: CoQ reductase (Complex I) activity in the hypoxic/reoxygenated rat heart. J Biochem 274: 133-137, 1991.

25.   Kristián, T, and Siesjö BK. Calcium in ischemic cell death. Stroke 29: 705-718, 1998[Abstract/Free Full Text].

26.   Kroemer, G, Dallaporta B, and RescheRigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998[Web of Science][Medline].

27.   Lacza, Z, Puskar M, Figueroa JP, Zhang J, Rajapakse N, and Busija DW. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic Biol Med 31: 1609-1615, 2001[Web of Science][Medline].

28.   Lin, TN, He YY, Wu G, Khan M, and Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121, 1993[Abstract/Free Full Text].

29.   Lisa, FD, and Bernardi P. Mitochondrial function as a determinant of recovery or death in cell response to injury. Mol Cell Biochem 184: 379-391, 1998[Web of Science][Medline].

30.   Liu, Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998[Abstract/Free Full Text].

31.   Ockaili, R, Emani VR, Okubo S, Brown M, Krottapalli K, and Kukreja RC. Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol Heart Circ Physiol 277: H2425-H2434, 1999[Abstract/Free Full Text].

32.   Paxinos, G, and Watson C. The Rat Brain in Stereotactic Coordinates (2nd ed.). Sydney, Australia: Academic, 1986.

33.   Piot, CA, Padmanaban D, Ursell PC, Sievers RE, and Wolfe CL. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 96: 1598-1604, 1997[Abstract/Free Full Text].

34.   Rajapakse, N, Shimizu K, Payne M, and Busija DW. Isolation and characterization of intact mitochondria from neonatal rat brain. Brain Res 8: 176-183, 2001.

35.   Sargent, CA, Smith MA, Dzwonczyk S, Sleph PG, and Grover GJ. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents. J Pharmacol Exp Ther 259: 97-103, 1991[Abstract/Free Full Text].

36.   Sarti, P, Lendaro E, Ippoliti R, Bellelli A, Benedetti PA, and Brunori M. Modulation of mitochondrial respiration by nitric oxide: investigation by single cell fluorescence microscopy. FASEB J 13: 191-197, 1999[Abstract/Free Full Text].

37.   Shimizu, K, Miller AW, Erdös Bari F, and Busija DW. Role of endothelium in hyperemia during cortical spreading depression in the rat. Brain Res 928: 40-49, 2002[Web of Science][Medline].

38.   Shimizu, K, Rajapakse N, and Busija DW. Neuroprotective effects of diazoxide, a selective opener of mitochondrial ATP-sensitive potassium channels, against transient focal cerebral ischemia in rats. Soc Neurosci Abstr 27: Program 332.11, 2001.

39.   Shimizu, K, Veltkamp R, and Busija DW. Characteristics of induced spreading depression after transient focal ischemia in the rat. Brain Res 861: 316-324, 2000[Web of Science][Medline].

40.   Siesjö, BK, Elmér E, Janelidze S, Keep M, Kristián T, Ouyang YB, and Uchino H. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir 73, Suppl: 7-13, 2000.

41.   Sims, NR. Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J Neurochem 55: 698-707, 1990[Web of Science][Medline].

42.   Swanson, RA, Morton MT, Wu TG, Savalos RA, Davidson C, and Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10: 290-293, 1990[Web of Science][Medline].

43.   Takaba, H, Nagao T, Yao H, Kitazono T, Ibayashi S, and Fujishima M. An ATP-sensitive potassium channel activator reduces infarct volume in focal cerebral ischemia in rats. Am J Physiol Regul Integr Comp Physiol 273: R583-R586, 1997[Abstract/Free Full Text].

44.   Takashi, E, Wang Y, and Ashraf M. Activation of mitochondrial KATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 85: 1146-1153, 1999[Abstract/Free Full Text].

45.   Veltkamp, R, Domoki F, Bari F, and Busija DW. Potassium channel activators protect the N-methyl-D-asparate-induced cerebral vascular dilation after combined hypoxia and ischemia in piglets. Stroke 29: 837-842, 1998[Abstract/Free Full Text].

46.   Veltkamp, R, Warner DS, Domoki F, Brinkhous AD, Toole JF, and Busija DW. Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res 853: 68-73, 2000[Web of Science][Medline].

47.   Yamada, M, Isomoto S, Matsumoto S, Kondo C, Shindo T, Horio Y, and Kurachi Y. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. J Physiol 499: 715-720, 1997[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 283(3):H1005-H1011
0363-6135/02 $5.00 Copyright © 2002 the American Physiological Society



This article has been cited by other articles:


Home page
J. Physiol.Home page
M. E. Pamenter, D. S.-H. Shin, M. Cooray, and L. T. Buck
Mitochondrial ATP-sensitive K+ channels regulate NMDAR activity in the cortex of the anoxic western painted turtle
J. Physiol., February 15, 2008; 586(4): 1043 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev, January 1, 2008; 88(1): 211 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H.-S. Sun, Z.-P. Feng, T. Miki, S. Seino, and R. J. French
Enhanced Neuronal Damage After Ischemic Insults in Mice Lacking Kir6.2-Containing ATP-Sensitive K+ Channels
J Neurophysiol, April 1, 2006; 95(4): 2590 - 2601.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
T. Brustovetsky, N. Shalbuyeva, and N. Brustovetsky
Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain nonsynaptosomal mitochondria
J. Physiol., October 1, 2005; 568(1): 47 - 59.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/3/H1005    most recent
00054.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, K.
Right arrow Articles by Busija, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, K.
Right arrow Articles by Busija, D. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online